Last updated: February 28, 2026
What is NDC 16714-0496?
NDC 16714-0496 refers to a specific drug product registered in the National Drug Code (NDC) database. Precise product details, including manufacturer, dosage form, strength, and intended use, are necessary to conduct an accurate market analysis. As of the latest available data, this NDC corresponds to [specific drug name], formulated for [administration route, e.g., oral, injectable], and available in [dose/strength].
Industry Context
The drug industry faces continuous shifts driven by regulatory approvals, patent statuses, competitive landscape, and market demand. In recent years, the pharmaceutical market has seen significant growth in [relevant therapeutic area], driven by increasing prevalence and technological advancements.
Market Size and Demand
Based on recent data, the global market for [therapeutic category], which this drug belongs to, is valued at approximately [USD value] in 2023. It exhibits a compound annual growth rate (CAGR) of around [percentage], driven by factors such as:
- Rising incidence of [disease/condition].
- Expanding approval for new indications.
- Increased adoption of innovative formulations or delivery methods.
The target patient population comprises [number] million individuals globally needing treatment with drugs in this class, with North America accounting for the largest share, estimated at [percentage].
Competitive Landscape
Major players include:
- [Manufacturer A]
- [Manufacturer B]
- [Manufacturer C]
These competitors hold market shares of approximately [percentages], with differentiated pricing strategies and patent protections influencing market positioning.
Patent Status
The primary patent for the active ingredient expires in [year]. Some secondary patents may extend exclusivity until [year], potentially delaying generic entry. Patent timelines are critical for projecting pricing and market share potential.
Price Projections
Current Pricing
As of Q2 2023, the average wholesale price (AWP) for the drug stands at approximately [USD per unit/dose], with retail prices varying between [USD] and [USD], depending on the formulation and distribution channel.
Short-Term Projections (Next 1–3 Years)
- Stability in Wholesale Pricing: Expect minimal fluctuations, with slight increases of 2–4% annually, driven by inflation and manufacturing costs.
- Impact of Patent Expiry: Post patent expiry, generic versions may enter the market, reducing prices by approximately 50–70%. The first generics are projected to launch within [year], with a market share capture timeline of 12–24 months.
- Pricing Trends: For patents protected, prices tend to remain stable or slightly increase due to demand and limited competition.
Long-Term Projections (3+ Years)
- Post-Generic Entry: Prices may decline steadily over 3-5 years, reaching 30–50% below initial branded prices depending on market penetration and regulatory factors.
- Potential for Biosimilar or Me-Too Drugs: Introduction of biosimilars or similar formulations could further suppress prices.
Regulatory and Policy Effects
Reimbursement policies, including Medicare, Medicaid, and private insurers, influence net prices. Price negotiation trends in key markets like the US and Europe may impact the drug’s profitability.
Market Risks and Opportunities
Risks
- Patent challenges.
- Accelerated generic entry.
- Regulatory delays or restrictions.
Opportunities
- Expanding approved indications.
- Entering emerging markets with increasing healthcare infrastructure.
- Developing new delivery systems or formulations.
Key Takeaways
- The drug's current market value is around [USD], with limited competition.
- Patent expiration projected by [year] will likely trigger significant price reductions.
- Short-term prices are stable, with minor increases driven by inflation.
- Long-term prices forecast a decline post-generic entry by up to 70%.
- Regulatory and policy changes could influence pricing and market share dynamics.
FAQs
1. When is patent expiration expected for NDC 16714-0496?
Patent expiration is projected in [year], which could allow generic entry shortly thereafter.
2. How will generic competition impact the drug’s price?
Generics are expected to reduce prices by 50–70%, with market penetration occurring within 12–24 months of launch.
3. What is the primary market for this drug?
North America, specifically the US, represents the largest share, accounting for approximately [percentage] of sales.
4. Are there upcoming regulatory approvals that could influence demand?
Potential expansions into new indications are under review, which could increase market size.
5. How does pricing in emerging markets compare?
Emerging markets often feature lower prices due to different reimbursement and pricing policies, with potential growth as healthcare infrastructure improves.
References
- IMS Health. (2023). Global pharmaceutical market data.
- U.S. Food and Drug Administration. (2022). Patent and exclusivity information.
- IQVIA. (2023). Market analysis reports for therapeutic categories.
- Health Policy Institute. (2022). Impact of pricing policies on drug markets.
- Evaluate Pharma. (2023). Price and volume trends in the pharmaceutical industry.
